Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haruo Hirayama

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 24, 2012
[Cilostazol]Haruo Hirayama
The Journal of Invasive Cardiology|April 6, 2012
Management of drug-eluting stent restenosisKiyotake Ishikawa, Yutaka Aoyama, Haruo Hirayama
International Journal of Cardiology|April 1, 2014
Conversion from persistent to paroxysmal atrial fibrillation after pulmonary vein isolation is a good signAkinori Sairaku, Yukihiko Yoshida, Haruo Hirayama, et al.
American Heart Journal|January 22, 2005
The angiotensin II receptor blocker candesartan cilexetil reduces neointima proliferation after coronary stent implantation: a prospective randomized study under intravascular ultrasound guidanceOsamu Yoshida, Haruo Hirayama, Mamoru Nanasato, et al.
The Journal of Emergency Medicine|September 20, 2006
Predictors of in-hospital delay to reperfusion in patients with acute myocardial infarction in JapanYoshimi Fukuoka, Kathleen Dracup, Miyoshi Ohno, et al.
European Journal of Cardiovascular Nursing|May 10, 2005
Symptom severity as a predictor of reported differences of prehospital delay between medical records and structured interviews among patients with AMIYoshimi Fukuoka, Kathleen Dracup, Miyoshi Ohno, et al.
International Heart Journal|October 15, 2014
Impact of pulmonary vein isolation on fractionated atrial potentials and ganglionated plexi in patients with persistent atrial fibrillationAkinori Sairaku, Yukihiko Yoshida, Haruo Hirayama, et al.
Journal of Thrombosis and Thrombolysis|August 15, 2013
Periprocedural coagulability in patients undergoing ablation of atrial fibrillation: lessons from a periablation anticoagulation strategy of a brief withdrawal of warfarin without heparin bridgingAkinori Sairaku, Yukihiko Yoshida, Haruo Hirayama, et al.
Clinical Drug Investigation|October 2, 2013
A head-to-head comparison of periprocedural coagulability under anticoagulation with rivaroxaban versus dabigatran in patients undergoing ablation of atrial fibrillationAkinori Sairaku, Yukihiko Yoshida, Monami Ando, et al.
International Journal of Cardiology|December 10, 2013
Don't move during ablation of atrial fibrillation!Akinori Sairaku, Yukihiko Yoshida, Haruo Hirayama, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Nihon Rinsho. Japanese Journal of Clinical Medicine|April 24, 2012
[Cilostazol]Haruo Hirayama
The Journal of Invasive Cardiology|April 6, 2012
Management of drug-eluting stent restenosisKiyotake Ishikawa, Yutaka Aoyama, Haruo Hirayama
International Journal of Cardiology|April 1, 2014
Conversion from persistent to paroxysmal atrial fibrillation after pulmonary vein isolation is a good signAkinori Sairaku, Yukihiko Yoshida, Haruo Hirayama, et al.
American Heart Journal|January 22, 2005
The angiotensin II receptor blocker candesartan cilexetil reduces neointima proliferation after coronary stent implantation: a prospective randomized study under intravascular ultrasound guidanceOsamu Yoshida, Haruo Hirayama, Mamoru Nanasato, et al.
The Journal of Emergency Medicine|September 20, 2006
Predictors of in-hospital delay to reperfusion in patients with acute myocardial infarction in JapanYoshimi Fukuoka, Kathleen Dracup, Miyoshi Ohno, et al.
European Journal of Cardiovascular Nursing|May 10, 2005
Symptom severity as a predictor of reported differences of prehospital delay between medical records and structured interviews among patients with AMIYoshimi Fukuoka, Kathleen Dracup, Miyoshi Ohno, et al.
International Heart Journal|October 15, 2014
Impact of pulmonary vein isolation on fractionated atrial potentials and ganglionated plexi in patients with persistent atrial fibrillationAkinori Sairaku, Yukihiko Yoshida, Haruo Hirayama, et al.
Journal of Thrombosis and Thrombolysis|August 15, 2013
Periprocedural coagulability in patients undergoing ablation of atrial fibrillation: lessons from a periablation anticoagulation strategy of a brief withdrawal of warfarin without heparin bridgingAkinori Sairaku, Yukihiko Yoshida, Haruo Hirayama, et al.
Clinical Drug Investigation|October 2, 2013
A head-to-head comparison of periprocedural coagulability under anticoagulation with rivaroxaban versus dabigatran in patients undergoing ablation of atrial fibrillationAkinori Sairaku, Yukihiko Yoshida, Monami Ando, et al.
International Journal of Cardiology|December 10, 2013
Don't move during ablation of atrial fibrillation!Akinori Sairaku, Yukihiko Yoshida, Haruo Hirayama, et al.
Pageof 6